- Home
- HTCR vs IBIO Comparison
HTCR vs IBIO Comparison
Compare HTCR & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTCR
- IBIO
- Stock Information
- Founded
- HTCR 2009
- IBIO 2008
- Country
- HTCR Japan
- IBIO United States
- Employees
- HTCR N/A
- IBIO N/A
- Industry
- HTCR EDP Services
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- HTCR Technology
- IBIO Health Care
- Exchange
- HTCR Nasdaq
- IBIO Nasdaq
- Market Cap
- HTCR 10.3M
- IBIO 11.9M
- IPO Year
- HTCR 2022
- IBIO N/A
- Fundamental
- Price
- HTCR $0.49
- IBIO $0.66
- Analyst Decision
- HTCR
- IBIO Strong Buy
- Analyst Count
- HTCR 0
- IBIO 2
- Target Price
- HTCR N/A
- IBIO $5.50
- AVG Volume (30 Days)
- HTCR 82.7K
- IBIO 532.9K
- Earning Date
- HTCR 08-13-2025
- IBIO 09-19-2025
- Dividend Yield
- HTCR 4.12%
- IBIO N/A
- EPS Growth
- HTCR N/A
- IBIO N/A
- EPS
- HTCR N/A
- IBIO N/A
- Revenue
- HTCR $28,947,523.00
- IBIO $375,000.00
- Revenue This Year
- HTCR N/A
- IBIO $81.33
- Revenue Next Year
- HTCR $8.59
- IBIO N/A
- P/E Ratio
- HTCR N/A
- IBIO N/A
- Revenue Growth
- HTCR 59.42
- IBIO 650.00
- 52 Week Low
- HTCR $0.39
- IBIO $0.64
- 52 Week High
- HTCR $3.38
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- HTCR 48.71
- IBIO 33.40
- Support Level
- HTCR $0.48
- IBIO $0.71
- Resistance Level
- HTCR $0.53
- IBIO $0.78
- Average True Range (ATR)
- HTCR 0.04
- IBIO 0.03
- MACD
- HTCR 0.00
- IBIO -0.00
- Stochastic Oscillator
- HTCR 50.72
- IBIO 6.43
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.